Medicare Enrolled
Dr. Rohan Gupta, DO
Internal Medicine · Burleson, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gupta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gupta
Dr. Rohan Gupta is an internal medicine specialist in Burleson, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Gupta performed 113,783 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gupta received a total of $66,774 from 53 pharmaceutical and/or device companies across 206 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gupta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 0% volume in TX
$66,774 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗113,783
Medicare services
Top 0% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
39,750 | $1 | $3 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
29,760 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
27,150 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,329 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,800 | $1 | $52 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,129 | $93 | $250 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,073 | $137 | $350 |
| Injection, leucovorin calcium, per 50 mg | 924 | $3 | $15 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
889 | $12 | $70 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
660 | $2 | $5 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
648 | $19 | $125 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
576 | $102 | $412 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
377 | $93 | $275 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
340 | $23 | $100 |
| COVID-19 test, self-administered An FDA-approved, authorized, or cleared test kit for nonprescription self-administered and self-collected use. This code represents the provision of one test count. |
336 | $12 | $30 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
301 | $7 | $300 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
268 | $62 | $175 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
250 | $11 | $60 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
215 | $50 | $202 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
204 | $22 | $93 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
193 | $1 | $10 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
190 | $133 | $500 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
158 | $48 | $160 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
119 | $49 | $190 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
110 | $48 | $401 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
97 | $165 | $681 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 89 | $105 | $450 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
86 | $133 | $450 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
83 | $1,160 | $4,069 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
76 | $1 | $5 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
72 | $37 | $120 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
62 | $84 | $300 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
53 | $101 | $350 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
50 | $16 | $60 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $64 | $175 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
41 | $23 | $155 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
39 | $29 | $145 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
35 | $10 | $50 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
35 | $16 | $60 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
35 | $2 | $20 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
29 | $57 | $200 |
| New patient office visit, complex (60-74 min) | 26 | $172 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $125 | $400 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
22 | $62 | $250 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
16 | $77 | $338 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
16 | $49 | $161 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
36.2% high complexity
59.7% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$66,774
Total received (2018-2024)
Avg $9,539/year across 7 years
Top 2% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
206
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$33,937
2023
$18,187
2022
$2,663
2021
$7,317
2020
$1,006
2019
$3,043
2018
$621
Payments by company (2024)
Merck Sharp & Dohme LLC
$22,699
Daiichi Sankyo Inc.
$8,373
Novartis Pharmaceuticals Corporation
$2,221
GlaxoSmithKline, LLC.
$108
PFIZER INC.
$67
Tempus AI, Inc
$58
ABBVIE INC.
$56
ARRAY BIOPHARMA INC
$50
AstraZeneca Pharmaceuticals LP
$48
Kyowa Kirin, Inc.
$41
Janssen Biotech, Inc.
$34
SpringWorks Therapeutics, Inc.
$31
Kite Pharma, Inc.
$27
Alexion Pharmaceuticals, Inc.
$24
Celgene Corporation
$24
Geron Corporation
$21
Deciphera Pharmaceuticals Inc.
$19
Eisai Inc.
$18
SOBI, INC
$16
Top 3 companies account for 98.1% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$22,761
Daiichi Sankyo Inc.
$12,700
Seagen Inc.
$7,500
Rigel Pharmaceuticals, Inc.
$2,586
Kyowa Kirin, Inc.
$2,495
Novartis Pharmaceuticals Corporation
$2,398
BeiGene USA, Inc.
$2,297
Amgen Inc.
$2,113
PFIZER INC.
$1,966
Blueprint Medicines Corporation
$1,948
Celgene Corporation
$1,784
E.R. Squibb & Sons, L.L.C.
$1,760
Bayer Healthcare Pharmaceuticals Inc.
$1,028
GlaxoSmithKline, LLC.
$642
GENZYME CORPORATION
$510
Novocure GmbH
$200
Lilly USA, LLC
$199
Alexion Pharmaceuticals, Inc.
$195
Takeda Pharmaceuticals U.S.A., Inc.
$156
Janssen Biotech, Inc.
$133
Genentech USA, Inc.
$120
AbbVie, Inc.
$110
AstraZeneca Pharmaceuticals LP
$90
Astellas Pharma US Inc
$73
Kite Pharma, Inc.
$71
SANOFI-AVENTIS U.S. LLC
$67
Adaptive Biotechnologies Corporation
$67
PharmaEssentia USA Corporation
$65
Tempus AI, Inc
$58
ABBVIE INC.
$56
Eisai Inc.
$51
ARRAY BIOPHARMA INC
$50
MorphoSys, US Inc.
$44
Janssen Pharmaceuticals, Inc
$44
TESARO, Inc.
$38
Gilead Sciences, Inc.
$36
Siemens Medical Solutions USA, Inc.
$36
SpringWorks Therapeutics, Inc.
$31
Sun Pharmaceutical Industries Inc.
$29
Pharmacyclics LLC, An AbbVie Company
$26
Incyte Corporation
$24
Apellis Pharmaceuticals, Inc.
$24
AVEO Pharmaceuticals, Inc.
$22
Geron Corporation
$21
Agios Pharmaceuticals, Inc.
$21
Puma Biotechnology, Inc.
$19
Deciphera Pharmaceuticals Inc.
$19
EISAI INC.
$16
SOBI, INC
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
Karyopharm Therapeutics Inc.
$15
Secura Bio, Inc.
$14
Acrotech Biopharma LLC
$14
Top 3 companies account for 64.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Abraxane · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · Blincyto · CALQUENCE · COPIKTRA · DOPTELET · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · Empaveli · Enhertu · FOTIVDA · IBRANCE · ICLUSIG · IMBRUVICA · INJECTAFER · INLYTA · JEMPERLI · KEYTRUDA · KISQALI · Kerendia · Kyprolis · LIBTAYO · Lenvima · MEKINIST · MONJUVI · NINLARO · OGSIVEO · OJJAARA · OPDIVO · Odomzo · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYTELO · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · Software and Accessories · Stivarga · TAGRISSO · TECENTRIQ · TECVAYLI · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · Vanflyta · Venclexta · XALKORI · XARELTO · XPOVIO · Xospata · Xtandi · Yescarta · ZEJULA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
701
County median income
$81,826
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT AND WHITE EMERGENCY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gupta is a mixed practice specialist, with above-average Medicare volume (top 0% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gupta experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Gupta performed 39,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gupta receive payments from pharmaceutical companies?
Yes. Dr. Gupta received a total of $66,774 from 53 companies across 206 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gupta's costs compare to other internal medicine physicians in Burleson?
Dr. Gupta's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Burleson
Browse internal medicine physicians in Burleson ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology